Jiyan Chen

Dr. Jiyan Chen


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2021 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
YLYing-Wen Lin
Ying-Wen Lin
MJMei Jiang
Mei Jiang
XWXue-Biao Wei
Xue-Biao Wei
JHJie-Leng Huang
Jie-Leng Huang
ZSZedazhong Su
Zedazhong Su
DYDan-qing Yu
Dan-qing Yu
Background: Increased D-dimer levels have been shown to correlate with adverse outcomes in various clinical conditions. However, few studies with a large sample size have been performed thus far to evaluate the prognostic value of D-dimer in patients with infective endocarditis (IE). Methods: 613 patients with IE were included in the study and categorized into two groups according to the cut-off of D-dimer determined by receiver operating characteristic (ROC) curve analysis for in-hospital death: > 3.5 mg/L (n = 89) and ≤ 3.5 mg/L (n = 524). Multivariable regression analysis was used to determine the association of D-dimer with in-hospital adverse events and six-month death. Results: In-hospital death (22.5% vs. 7.3%), embolism (33.7% vs 18.2%), and stroke (29.2% vs 15.8%) were significantly higher in patients with D-dimer > 3.5 mg/L than in those with D-dimer ≤ 3.5 mg/L. Multivariable analysis showed that D-dimer was an independent risk factor for in-hospital adverse events (odds ratio = 1.11, 95% CI 1.03–1.19, P = 0.005). In addition, the Kaplan–Meier curve showed that the cumulative 6-month mortality was significantly higher in patients with D-dimer > 3.5 mg/L than in those with D-dimer ≤ 3.5 mg/L (log-rank test = 39.19, P < 0.0001). Multivariable Cox regression analysis showed that D-dimer remained a significant predictor for six-month death (HR 1.11, 95% CI 1.05–1.18, P < 0.001). Conclusions: D-dimer is a reliable prognostic biomarker that independently associated with in-hospital adverse events and six-month mortality in patients with IE.

2 November 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
XWXuebiao Wei
Xuebiao Wei
BFBingqi Fu
Bingqi Fu
XCXiaolan Chen
Xiaolan Chen
WCWeiTao Chen
WeiTao Chen
ZWZhenqian Wang
Zhenqian Wang
JCJiyan Chen
Jiyan Chen
Background: Increased uric acid (UA) levels have been reported to be associated with poor clinical outcomes in several conditions. However, the prognostic value of UA in patients with infective endocarditis (IE) is yet unknown.Methods: A total of 1,117 patients with IE were included and divided into two groups according to the current definition of hyperuricemia (UA>420 μmol/L in men and >360 μmol/L in women): hyperuricemia group (n=336) and normouricemia group (n=781). The association between the UA level and short-term outcomes were examined.Results: The in-hospital mortality was 6.2% (69/1117). Patients with hyperuricemia carried a higher risk of in-hospital death (9.8% vs. 4.6%, p=0.001). Hyperuricemia was not an independent risk factor for in-hospital death (adjusted odds ratio [aOR]=1.92, 95% confidence interval [CI]: 0.92-4.02, p=0.084). A U-shaped relationship was found between the UA level and in-hospital death (p400 and 400 μmol/L (adjusted hazard ratio [aHR]=3.54, 95%CI: 1.77-7.07, p<0.001) and <250 μmol/L (aHR=2.23, 95%CI: 1.03-4.80, p=0.041) were independent risk factors for the 6-month mortality.Conclusion: The previous definition of hyperuricemia was not suitable for risk assessment in patients with IE because of the U-shaped relationship between UA levels and in-hospital death. Low and high levels of UA were predictive of increased short-term mortality in IE patients.

1 January 2011 in Archives of Medical Science
Verified
Journal Article
Open access
DYDan-qing Yu
Dan-qing Yu
SLShu-Guang Lin
Shu-Guang Lin
JCJiyan Chen
Jiyan Chen
LXLing Xue
Ling Xue
Guang LiGuang Li
Guang Li
YZYing-Ling Zhou
Ying-Ling Zhou
Introduction : It is still controversial whether borderline lesions with a vulnerable plaque should be stented early or simply treated pharmacologically. No data exist concerning the potential effects of statin therapy on borderline vulnerable lesions in patients with acute coronary syndrome...

15 November 2023 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
XWXue-biao Wei
Xue-biao Wei
PRPeng Ran
Peng Ran
YNYuxin Nong
Yuxin Nong
TYTao Ye
Tao Ye
XJXuhua Jian
Xuhua Jian
JCJiyan Chen
Jiyan Chen

30 December 2020 in Medical Science Monitor
Verified
Journal Article
Closed access
JHJieleng Huang
Jieleng Huang
XWXuebiao Wei
Xuebiao Wei
YWYu Wang
Yu Wang
MJMei Jiang
Mei Jiang
YLYingwen Lin
Yingwen Lin
DYDan-qing Yu
Dan-qing Yu
Comparison of Prognostic Value Among 4 Risk Scores in Patients with Acute Coronary Syndrome: Findings from the Improving Care for Cardiovascular Disease in China-ACS (CCC-ACS) Project - Article abstract #928863

2 June 2022 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
YLYing-Wen Lin
Ying-Wen Lin
JHJie-Leng Huang
Jie-Leng Huang
XWXue-Biao Wei
Xue-Biao Wei
MJMei Jiang
Mei Jiang
PRPeng Ran
Peng Ran
DYDan-qing Yu
Dan-qing Yu